Download PDF

Other users also viewed these articles

Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023 Linda E. Munoz-Espinosa; Aldo Torre; Laura Cisneros; Iaarah Montalvo-Gordon; René Malé-Velázquez; Scherezada Mejía; Juan Ramón Aguilar-Ramírez; Javier Lizardi-Cervera; María E. Icaza-Chávez; Frida Gasca-Díaz; Larissa Hernández-Hernández; Paula Cordero-Perez; Luis A. Chi-Cervera; Lilian Torres-Made; Fátima Rodríguez-Álvarez; Graciela Tapia; Jorge Luis Poo;
Ann Hepatol. 2024;29 Supl 2:
Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990¿2050 Yujiao Deng; Jingyue Tan; Jian Zu; Zixuan Xing; Zhanpeng Yang; Yue Zhang; Yajing Bo; Xu Gao; Enrui Xie; Yuan Wang; Meijuan Han; Fanpu Ji; Yang Yang;
Ann Hepatol. 2026;31:
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma Stephen Lam Chan; Richard S. Finn; Julien Edeline; Sadahisa Ogasawara; Jennifer J. Knox; Bruno Daniele; Baek-Yeol Ryoo; Philippe Merle; Mohamed Bouattour; Ho-Yeong Lim; Yee Chao; Thomas Yau; Barbara Anne Haber; Usha Malhotra; Abby B. Siegel; Chih-Chin Liu; Masatoshi Kudo; Ann-Lii Cheng;
10.1016/j.aohep.2025.102169